Journal of Embryo Transfer (한국수정란이식학회지)

The Korean Society of Embryo Transfer (한국수정란이식학회)
권호 표지
DOI QR코드

DOI QR Code

Nuclear Transfer using Human CD59 and IL-18BP Double Transgenic Fetal Fibroblasts in Miniature Pigs

  • Ryu, Junghyun (Dept. of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) ;
  • Kim, Minjeong (Dept. of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) ;
  • Ahn, Jin Seop (Dept. of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) ;
  • Ahn, Kwang Sung (Dept. of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University) ;
  • Shim, Hosup (Dept. of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine, Dankook University)
  • Received : 2016.02.15
  • Accepted : 2016.03.30
  • Published : 2016.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Xenotransplantation involves multiple steps of immune rejection. The present study was designed to produce nuclear transfer embryos, prior to the production of transgenic pigs, using fibroblasts carrying transgenes human complement regulatory protein hCD59 and interleukin-18 binding protein (hIL-18BP) to reduce hyperacute rejection (HAR) and cellular rejection in pig-to-human xenotransplantation. In addition to the hCD59-mediated reduction of HAR, hIL-18BP may prevent cellular rejection by inhibiting the activation of natural killer cells, activated T-cell proliferation, and induction of $IFN-{\gamma}$. Transgene construct including hCD59 and ILI-18BP was introduced into miniature pig fetal fibroblasts. After antibiotic selection of double transgenic fibroblasts, integration of the transgene was screened by PCR, and the transgene expression was confirmed by RT-PCR. Treatment of human serum did not affect the survival of double-transgenic fibroblasts, whereas the treatment significantly reduced the survival of non-transgenic fibroblasts (p<0.01), suggesting alleviation of HAR. Among 337 reconstituted oocytes produced by nuclear transfer using the double transgenic fibroblasts, 28 (15.3%) developed to the blastocyst stage. Analysis of individual embryos indicated that 53.6% (15/28) of embryos contained the transgene. The result of the present study demonstrates the resistance of hCD59 and IL-18BP double-transgenic fibroblasts against HAR, and the usefulness of the transgenic approach may be predicted by RT-PCR and cytolytic assessment prior to actual production of transgenic pigs. Further study on the transfer of these embryos to surrogates may produce transgenic clone miniature pigs expressing hCD59 and hIL-18BP for xenotransplantation.

Keywords

References

  1. Ahn KS, Kim YJ, Kim M, Lee BH, Heo SY, Kang MJ, Kang YK, Lee JW, Lee KK, Kim JH, Nho WG, Hwang SS, Woo JS, Park JK, Park SB and Shim H. 2011. Resurrection of an alpha-1,3-galactosyltransferase gene-targeted miniature pig by recloning using postmortem ear skin fibroblasts. Theriogenology 15:933-939.
  2. Bach FH. 1998. Xenotransplantation: Problems and prospects. Annu. Rev. Med. 49:301-310. https://doi.org/10.1146/annurev.med.49.1.301
  3. Chen RH, Naficy S, Logan JS, Diamond LE and Adams DH. 1999. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 6:194-200. https://doi.org/10.1034/j.1399-3089.1999.00017.x
  4. Fodor WL, Williams BL, Matis LA, Madri JA, Rollins SA, Knight JW, Velander W and Squinto SP. 1994. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc. Natl. Acad. Sci. U. S. A. 91:11153-11157. https://doi.org/10.1073/pnas.91.23.11153
  5. Lee JH, Lee HJ, Nahm KM, Jeon HY, Hwang WS, Paik NW and Rho HM. 2006. Effects of combined expression of human complement regulatory proteins and H-transferase on the inhibition of complement-mediated cytolysis in porcine embryonic fibroblasts. Transplant. Proc. 38:1618-1621. https://doi.org/10.1016/j.transproceed.2006.02.129
  6. Liszewski MK, Farries TC, Lublin DM, Rooney IA and Atkinson JP. 1996. Control of the complement system. Adv. Immunol. 61:201-283.
  7. Machaty Z, Bondioli KR, Ramsoondar JJ and Fodor WL. 2002. The use of nuclear transfer to produce transgenic pigs. Cloning Stem Cells. 4:21-27. https://doi.org/10.1089/153623002753632011
  8. McCurry KR, Kooyman DL, Alvarado CG, Cotterell AH, Martin MJ, Logan JS and Platt JL. 1995. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat. Med. 1:423-427. https://doi.org/10.1038/nm0595-423
  9. Mollnes TE and Fiane AE. 2003. Perspectives on complement in xenotransplantation. Mol Immunol. 40:135-143. https://doi.org/10.1016/S0161-5890(03)00106-8
  10. Muneta Y, Mori Y, Shimoji Y and Yokomizo Y. 2002. Porcine interleukin 18: Cloning, characterization of the cDNA and expression with the baculovirus system. Cytokine 12:566-572.
  11. Nakanishi K, Yoshimoto T, Tsutsui H and Okamura H. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu. Rev. Immunol. 19:423-474. https://doi.org/10.1146/annurev.immunol.19.1.423
  12. Niemann H. 2001. Current status and perspectives for the generation of transgenic pigs for xenotransplantation. Annu. Transplant. 6:6-9.
  13. Piedrahita JA and Mir B. 2004. Cloning and transgenesis in mammals: Implications for xenotransplantation. Am. J. Transplant. 4(Suppl. 6):43-50. https://doi.org/10.1111/j.1600-6135.2004.0344.x
  14. Pino-Chavez G. 2001. Differentiating acute humoral from acute cellular rejection. histopathologically. Graft 4:60-63. https://doi.org/10.1177/152216280100400116
  15. Rollins SA, Zhao J, Ninomiya H and Sims PJ. 1991. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9. J. Immunol. 146:2345-2351.
  16. Satyananda V, Hara H, Ezzelarab MB, Phelps C, Ayares D and Cooper DK. 2013. New concepts of immune modulation in xenotransplantation. Transplantation 96:937-945. https://doi.org/10.1097/TP.0b013e31829bbcb2
  17. Won JY, Ahn KS, Sorrell AM, Shin S, Heo SY, Kang JH, Park JK, Chang WK and Shim H. 2009. Cytolytic assessment of hyperacute rejection and production of nuclear transfer embryos using hCD46-transgenic porcine embryonic germ cells. Zygote 17:101-108. https://doi.org/10.1017/S096719940800511X
  18. Yang YG and Sykes M. 2007. Xenotransplantation: Current status and a perspective on the future. Nat. Rev. Immunol. 7:519-531. https://doi.org/10.1038/nri2099